Editors:
Discusses the progress in linking the biology of ovarian cancer with novel targets and innovative therapies entering clinical trials.
Provides an up-to-date perspective on successful therapeutic developments as a partnership between laboratory-based and clinical-based research scientists.
Identifies those areas of translational research which we believe have shown the most promise, or are likely to do so, in the treatment of ovarian cancer.
Includes supplementary material: sn.pub/extras
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (13 chapters)
-
Front Matter
-
Back Matter
Editors and Affiliations
-
Royal Marsden Hospital, Drug Development Unit, Institute of Cancer Research, Sutton, United Kingdom
Stan Kaye
-
, Department of Surgery and Cancer, Imperial College London, London, United Kingdom
Robert Brown
-
, Department of Surgery and Cancer, Imperial College, London, United Kingdom
Hani Gabra
-
, Department of Medicine, Royal Marsden Hospital, London, United Kingdom
Martin Gore
Bibliographic Information
Book Title: Emerging Therapeutic Targets in Ovarian Cancer
Editors: Stan Kaye, Robert Brown, Hani Gabra, Martin Gore
DOI: https://doi.org/10.1007/978-1-4419-7216-3
Publisher: Springer New York, NY
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Science+Business Media, LLC 2011
Hardcover ISBN: 978-1-4419-7215-6Published: 24 November 2010
Softcover ISBN: 978-1-4899-8233-9Published: 27 November 2014
eBook ISBN: 978-1-4419-7216-3Published: 23 November 2010
Edition Number: 1
Number of Pages: XIII, 291
Topics: Cancer Research, Pharmacology/Toxicology